Tenaerts, Pamela
Madre, Leanne
Archdeacon, Patrick
Califf, Robert M.
Article History
First Online: 31 October 2014
Competing interests
: R.M.C has received research grants from Amylin, Bristol-Myers Squibb, Eli Lilly, Janssen Research and Development, Merck and Novartis, and consultancy fees from Medscape, Amgen and Novartis. He also has ownership interest in N30 Pharma and Portola. P.T., L.M. and P.A. declare no competing interests.